|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:approvalYear
|
2013
|
|
gptkbp:approvedBy
|
gptkb:FDA
gptkb:EMA
|
|
gptkbp:associatedWith
|
gptkb:thalidomide
gptkb:lenalidomide
|
|
gptkbp:ATCCode
|
L04AX06
|
|
gptkbp:brand
|
gptkb:pomalidomide
|
|
gptkbp:chemicalFormula
|
C13H11N3O4
|
|
gptkbp:contraindication
|
pregnancy
|
|
gptkbp:drugClass
|
immunomodulatory drug
|
|
gptkbp:form
|
capsule
|
|
gptkbp:genericName
|
gptkb:pomalidomide
|
|
gptkbp:hasBoxedWarning
|
venous thromboembolism
embryo-fetal toxicity
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Pomalyst
|
|
gptkbp:indication
|
gptkb:AIDS-related_Kaposi_sarcoma
multiple myeloma
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Celgene
|
|
gptkbp:marketedIn
|
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:mechanismOfAction
|
inhibits proliferation and induces apoptosis of hematopoietic tumor cells
|
|
gptkbp:patent
|
gptkb:Celgene
|
|
gptkbp:pregnancyCategory
|
X
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
gptkb:anemia
constipation
fatigue
infections
neutropenia
thrombocytopenia
|
|
gptkbp:bfsParent
|
gptkb:Celgene
|
|
gptkbp:bfsLayer
|
6
|